WO2003106666A3 - Protein c variants with altered properties - Google Patents
Protein c variants with altered properties Download PDFInfo
- Publication number
- WO2003106666A3 WO2003106666A3 PCT/DK2003/000392 DK0300392W WO03106666A3 WO 2003106666 A3 WO2003106666 A3 WO 2003106666A3 DK 0300392 W DK0300392 W DK 0300392W WO 03106666 A3 WO03106666 A3 WO 03106666A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protein
- variants
- altered properties
- treatment
- residue
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6464—Protein C (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4866—Protein C (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003232176A AU2003232176A1 (en) | 2002-06-14 | 2003-06-13 | Protein c variants with altered properties |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38889202P | 2002-06-14 | 2002-06-14 | |
US60/388,892 | 2002-06-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003106666A2 WO2003106666A2 (en) | 2003-12-24 |
WO2003106666A3 true WO2003106666A3 (en) | 2007-11-15 |
Family
ID=29736559
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DK2003/000392 WO2003106666A2 (en) | 2002-06-14 | 2003-06-13 | Protein c variants with altered properties |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003232176A1 (en) |
WO (1) | WO2003106666A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004113385A1 (en) * | 2003-06-20 | 2004-12-29 | Maxygen Holdings Ltd. | Protein c propeptide variants |
WO2006044294A2 (en) * | 2004-10-14 | 2006-04-27 | Eli Lilly And Company | Human protein c analogs |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5453373A (en) * | 1992-05-21 | 1995-09-26 | Eli Lilly And Company | Protein C derivatives |
WO1998044000A1 (en) * | 1997-04-03 | 1998-10-08 | T.A.C. Thrombosis And Coagulation Aktiebolag | Recombinant protein c and protein s variants |
WO2002032461A2 (en) * | 2000-10-18 | 2002-04-25 | Maxygen Aps | Protein c or activated protein c-like molecules |
-
2003
- 2003-06-13 WO PCT/DK2003/000392 patent/WO2003106666A2/en not_active Application Discontinuation
- 2003-06-13 AU AU2003232176A patent/AU2003232176A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5453373A (en) * | 1992-05-21 | 1995-09-26 | Eli Lilly And Company | Protein C derivatives |
WO1998044000A1 (en) * | 1997-04-03 | 1998-10-08 | T.A.C. Thrombosis And Coagulation Aktiebolag | Recombinant protein c and protein s variants |
WO2002032461A2 (en) * | 2000-10-18 | 2002-04-25 | Maxygen Aps | Protein c or activated protein c-like molecules |
Non-Patent Citations (2)
Title |
---|
ANDREW J. GALE ET AL: "The autolysis loop of activated protein C interacts with factor Va and differentiates between the Arg506 and Arg306 cleavage sites", BLOOD, vol. 96, no. 2, July 2000 (2000-07-01), pages 585 - 593, XP002255339 * |
ROLF M. MESTERS ET AL: "Interactions and inhibition of blood coagulation factor Va involving residues 311-325 of activated protein C", PROTEIN SCIENCE, vol. 2, 1993, pages 1482 - 1489, XP002255340 * |
Also Published As
Publication number | Publication date |
---|---|
WO2003106666A2 (en) | 2003-12-24 |
AU2003232176A8 (en) | 2003-12-31 |
AU2003232176A1 (en) | 2003-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE2021C505I2 (en) | ||
WO2003101401A3 (en) | Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer | |
DE60028970D1 (en) | AT HER2 BINDING PEPTIDE COMPOUNDS | |
WO2000078344A8 (en) | Prion protein peptides and uses thereof | |
HK1087398A1 (en) | 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases | |
YU37304A (en) | Specific binding agents of human angiopoietin-2 | |
MXPA02011656A (en) | Nrg 2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods. | |
HK1095357A1 (en) | Factor vii or viia gla domain variants | |
MY136095A (en) | Use of human anti-ctla-4 antibodies for treatment of cancer | |
EP2537524A3 (en) | Treatment of T-cell mediated diseases | |
WO2003096990A3 (en) | Protein cages for the delivery of medical imaging and therapy | |
WO2005082399A3 (en) | Treatment of bacterial infections | |
IL171384A (en) | Use of slurp-1 in the preparation of medicaments for the treatment of neurological disorders | |
WO2003048205A3 (en) | Novel proteins with il-6 inhibiting activity | |
YU68702A (en) | Novel lhrh-antagonists, production and use thereof as medicament | |
GB0507598D0 (en) | Composition | |
MXPA02000680A (en) | Vgf polypeptides and methods of treating vgf-related disorders. | |
WO2001007479A3 (en) | Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases | |
WO2003106666A3 (en) | Protein c variants with altered properties | |
PL357999A1 (en) | Lhrh-antagonists, production and use thereof as medicament | |
WO2004113386A3 (en) | Modified hirudin proteins and t-cell epitopes in hirudin | |
IL174134A0 (en) | Use of a protein in the preparation of a medicament for treatment of fibrotic diseases | |
WO2007049065A3 (en) | Vwfa, collagen and kunitz domain containing protein | |
WO2003086301A3 (en) | Antibodies that specifically bind to tr2 | |
TW200517125A (en) | Pharmaceutical composition for treatment of solid cancers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |